Contineum Therapeutics, Inc. SEC filings CTNM

Contineum Therapeutics, Inc. has 201 filings in SEC EDGAR's recent list, going back to Dec 13, 2023. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Contineum Therapeutics, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G Ownership over 5% (passive) Nov 5, 2026 —
144 Notice of proposed sale Nov 4, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Oct 28, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 28, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Oct 22, 2026 —
144 Notice of proposed sale Oct 1, 2026 —
4 Insider transaction Sep 8, 2026 Sep 8, 2026
144 Notice of proposed sale Sep 8, 2026 —
144 Notice of proposed sale Sep 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 3, 2026 Aug 3, 2026
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jul 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 17, 2026 —
4 Insider transaction Jul 10, 2026 Jul 8, 2026
4 Insider transaction Jul 8, 2026 Jul 8, 2026
144 Notice of proposed sale Jul 8, 2026 —
4 Insider transaction Jul 2, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
144 Notice of proposed sale Jul 1, 2026 —
144 Notice of proposed sale Jun 30, 2026 —
144 Notice of proposed sale Jun 30, 2026 —
144 Notice of proposed sale Jun 30, 2026 —
4 Insider transaction Jun 26, 2026 Jun 26, 2026
4 Insider transaction Jun 26, 2026 Jun 26, 2026
4 Insider transaction Jun 26, 2026 Jun 26, 2026
4 Insider transaction Jun 26, 2026 Jun 26, 2026
4 Insider transaction Jun 26, 2026 Jun 26, 2026
4 Insider transaction Jun 26, 2026 Jun 26, 2026
4 Insider transaction Jun 26, 2026 Jun 26, 2026
4 Insider transaction Jun 1, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 1, 2026 May 1, 2026
144 Notice of proposed sale May 1, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 17, 2026 —
4 Insider transaction Apr 6, 2026 Apr 6, 2026
144 Notice of proposed sale Apr 6, 2026 —
4 Insider transaction Mar 2, 2026 Mar 2, 2026
4 Insider transaction Mar 2, 2026 Mar 2, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 13, 2026 Feb 11, 2026
4 Insider transaction Feb 13, 2026 Feb 11, 2026
144 Notice of proposed sale Feb 11, 2026 —
144 Notice of proposed sale Feb 11, 2026 —
4 Insider transaction Feb 5, 2026 Feb 3, 2026
144 Notice of proposed sale Feb 3, 2026 —
4 Insider transaction Jan 30, 2026 Jan 30, 2026
4 Insider transaction Jan 30, 2026 Jan 30, 2026
4 Insider transaction Jan 30, 2026 Jan 30, 2026
4 Insider transaction Jan 30, 2026 Jan 30, 2026
4 Insider transaction Jan 30, 2026 Jan 28, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 29, 2026 —
4 Insider transaction Jan 6, 2026 Jan 5, 2026
144 Notice of proposed sale Jan 5, 2026 —
4 Insider transaction Dec 30, 2025 Dec 29, 2025
4 Insider transaction Dec 30, 2025 Dec 23, 2025
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 23, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 4, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 5, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jul 25, 2025 —
4 Insider transaction Jun 26, 2025 Jun 26, 2025
4 Insider transaction Jun 26, 2025 Jun 26, 2025
4 Insider transaction Jun 26, 2025 Jun 26, 2025
4 Insider transaction Jun 26, 2025 Jun 26, 2025
4 Insider transaction Jun 26, 2025 Jun 26, 2025
4 Insider transaction Jun 26, 2025 Jun 26, 2025
4 Insider transaction Jun 26, 2025 Jun 26, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
4 Insider transaction Apr 28, 2025 Apr 28, 2025
3 Initial insider ownership Apr 28, 2025 Apr 28, 2025
4 Insider transaction Mar 17, 2025 Mar 14, 2025
3 Initial insider ownership Mar 17, 2025 Mar 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Jan 31, 2025 Jan 31, 2025
4 Insider transaction Jan 31, 2025 Jan 31, 2025
4 Insider transaction Jan 31, 2025 Jan 31, 2025
4 Insider transaction Jan 31, 2025 Jan 31, 2025
4 Insider transaction Jan 31, 2025 Jan 31, 2025
4 Insider transaction Nov 27, 2024 Nov 25, 2024
4 Insider transaction Nov 20, 2024 Nov 18, 2024
144 Notice of proposed sale Nov 18, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SCHEDULE 13G Ownership over 5% (passive) Oct 31, 2024 —
4 Insider transaction Aug 14, 2024 Aug 13, 2024
4 Insider transaction Jun 24, 2024 Jun 24, 2024
3 Initial insider ownership Jun 24, 2024 Jun 24, 2024
4 Insider transaction Jun 3, 2024 Jun 3, 2024
3 Initial insider ownership Jun 3, 2024 May 30, 2024
4 Insider transaction May 29, 2024 May 24, 2024
4 Insider transaction May 29, 2024 May 24, 2024
4 Insider transaction May 29, 2024 May 24, 2024
4 Insider transaction May 29, 2024 May 24, 2024
4 Insider transaction May 29, 2024 May 24, 2024
4 Insider transaction May 29, 2024 May 24, 2024
4 Insider transaction May 29, 2024 May 24, 2024
4 Insider transaction May 29, 2024 May 24, 2024
4 Insider transaction May 29, 2024 May 24, 2024
3 Initial insider ownership May 20, 2024 May 20, 2024
4 Insider transaction May 20, 2024 May 20, 2024
SC 13G Ownership over 5% (passive) Apr 15, 2024 —
SC 13G Ownership over 5% (passive) Apr 15, 2024 —
4 Insider transaction Apr 11, 2024 Apr 9, 2024
SC 13G Ownership over 5% (passive) Apr 10, 2024 —
3 Initial insider ownership Apr 10, 2024 Apr 9, 2024
3 Initial insider ownership Apr 4, 2024 Apr 4, 2024
3 Initial insider ownership Apr 4, 2024 Apr 4, 2024
3 Initial insider ownership Apr 4, 2024 Apr 4, 2024
3 Initial insider ownership Apr 4, 2024 Apr 4, 2024
3 Initial insider ownership Apr 4, 2024 Apr 4, 2024
3 Initial insider ownership Apr 4, 2024 Apr 4, 2024
3 Initial insider ownership Apr 4, 2024 Apr 4, 2024
3 Initial insider ownership Apr 4, 2024 Apr 4, 2024
3 Initial insider ownership Apr 4, 2024 Apr 4, 2024

Showing 125 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CTNM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1855175

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.